Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- Check4 days agoChange DetectedThe study record now shows that recruitment is closed (no longer looking for participants) and includes a new revision tag v3.6.0 in the history.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page history now includes a new revision label v3.5.5, replacing the previous v3.5.4, indicating the study record has been updated.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page footer revision label was updated from v3.5.3 to v3.5.4. This indicates a new revision of the page was published.SummaryDifference0.1%

- Check47 days agoChange DetectedThe Record History now shows a new revision entry (v3.5.3) replacing the previous v3.5.2, indicating an administrative update to the page's revision history.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded a new revision entry for version v3.5.2 and removed the previous v3.5.0 from the study record history.SummaryDifference0.1%

- Check90 days agoChange Detected- Added revision entry v3.5.0 - Removed revision entry v3.4.3SummaryDifference0.1%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.